NATCO PHARMA OPPOSES PATENT FILED BY TEVA PHARMACEUTICALS IN INDIA

Search News

Natco Pharma has opposed a patent filed by Teva Pharmaceuticals in India. The US-based drug maker had objected to Natco manufacturing a generic version of Copaxone. The Indian Patent Office refused to grant Teva the patent application and permitted Natco to supply Glatiramer Acetate, the generic make in India and other countries. “We have long maintained the composition claimed in this request was an obvious variation of compositions in the public domain and the current decision removes a potential obstacle to providing a more affordable version, said Natco CMD V Nannapaneni.

Find Lawyer / Law Firm

Extradition Law in India

Every time an offender stealthily leaves India to take refuge in another country, the Government of India starts all over again with its strategy of bringing him back to the nation to make him stan More

Legal Consultation - Consult over phone, chat or send questions

Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion  More